An Impressive Approach in Nuclear Medicine: Theranostics

Area of Science:

• Nuclear Medicine
• Oncology
• Radiochemistry

Background:

• Radiometal-based theranostics integrates diagnostic and therapeutic agents targeting the same molecule.
• This approach represents a significant advancement in nuclear medicine, emerging in the early 2000s.
• Radioligand therapy is a key application within theranostics.

Purpose of the Study:

• To highlight the advancements and applications of radiometal-based theranostics.
• To discuss the role of theranostics in targeted molecular imaging and therapy.
• To emphasize the benefits of combined diagnostic and therapeutic strategies in oncology.

Main Methods:

• Review of radiometal-based theranostic concepts and applications.
• Discussion of specific examples like prostate-specific membrane antigen (PSMA) targeted therapy for prostate cancer.
• Exploration of somatostatin receptor targeted imaging and therapy for neuroendocrine tumors (NETs).

Main Results:

• Theranostics offers a unified approach for simultaneous imaging and treatment.
• Targeted agents like PSMA and somatostatin receptors enable precise molecular targeting.
• The combined strategy improves patient prognostication and therapeutic decision-making.

Conclusions:

• Radiometal theranostics, particularly radioligand therapy, offers a powerful paradigm in nuclear medicine.
• Targeted molecular approaches enhance the efficacy and precision of cancer treatment.
• Integrated imaging and therapy improve patient management and outcomes in conditions like prostate cancer and NETs.